A newly identified compound activating <scp>UCP1</scp> inhibits obesity and its related metabolic disorders
Ken Onodera(Iwate Medical University), Yasushi Ishigaki(Iwate Medical University)
Cited by 5
Related Papers
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
|Journal of Atherosclerosis and Thrombosis|2023|269
Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
|Journal of Atherosclerosis and Thrombosis|2018|226